Hohaus, S., Funk, L., Martin, S., Schlenk, R. F., Abdallah Khalafallah, A., Hahn, U., . . . Haas, R. (1999). Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer. British journal of cancer, 79(9), . https://doi.org/10.1038/sj.bjc.6690239
Chicago-Zitierstil (17. Ausg.)Hohaus, Stefan, et al. "Stage III and Oestrogen Receptor Negativity Are Associated with Poor Prognosis After Adjuvant High-dose Therapy in High-risk Breast Cancer." British Journal of Cancer 79, no. 9 (1999). https://doi.org/10.1038/sj.bjc.6690239.
MLA-Zitierstil (9. Ausg.)Hohaus, Stefan, et al. "Stage III and Oestrogen Receptor Negativity Are Associated with Poor Prognosis After Adjuvant High-dose Therapy in High-risk Breast Cancer." British Journal of Cancer, vol. 79, no. 9, 1999, https://doi.org/10.1038/sj.bjc.6690239.